When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?
Considering that I’m a journalist, it’s not a surprise that I believe that knowledge is power—especially when it comes to health. Up to 80% of chronic diseases and premature death could be prevented ...
It’s common to wait until something feels “off” before making an appointment to see a healthcare provider. But waiting for noticeable symptoms can mean missing the chance to catch health issues early.
The field of Alzheimer’s disease (AD) research has evolved significantly, shifting from a sole reliance on clinical diagnosis to an integrated approach ...
Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
Please provide your email address to receive an email when new articles are posted on . There are several benefits that would come with having a prognostic IPF biomarker. A panel of five serum ...
Biomarker testing uses blood, saliva, or tissue to measure specific health metrics and provide insights into your body’s functioning. Testing can identify potential health issues early, track changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results